154 related articles for article (PubMed ID: 19570680)
1. Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease.
Huang CW; Lui CC; Chang WN; Lu CH; Wang YL; Chang CC
J Clin Neurosci; 2009 Oct; 16(10):1283-6. PubMed ID: 19570680
[TBL] [Abstract][Full Text] [Related]
2. Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease.
Elgh E; Lindqvist Astot A; Fagerlund M; Eriksson S; Olsson T; Näsman B
Biol Psychiatry; 2006 Jan; 59(2):155-61. PubMed ID: 16125145
[TBL] [Abstract][Full Text] [Related]
3. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
[TBL] [Abstract][Full Text] [Related]
5. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline.
den Heijer T; van der Lijn F; Koudstaal PJ; Hofman A; van der Lugt A; Krestin GP; Niessen WJ; Breteler MM
Brain; 2010 Apr; 133(Pt 4):1163-72. PubMed ID: 20375138
[TBL] [Abstract][Full Text] [Related]
6. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
[TBL] [Abstract][Full Text] [Related]
7. [Clinical presentation of Moroccan cases with Alzheimer's disease].
El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
[TBL] [Abstract][Full Text] [Related]
8. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
[TBL] [Abstract][Full Text] [Related]
9. Five-year retrospective changes in hippocampal atrophy and cognitive screening test performances in very mild Alzheimer's disease: the Tajiri Project.
Yamaguchi S; Meguro K; Shimada M; Ishizaki J; Yamadori A; Sekita Y
Neuroradiology; 2002 Jan; 44(1):43-8. PubMed ID: 11942499
[TBL] [Abstract][Full Text] [Related]
10. Altered circadian cortisol secretion in Alzheimer's disease: clinical and neuroradiological aspects.
Giubilei F; Patacchioli FR; Antonini G; Sepe Monti M; Tisei P; Bastianello S; Monnazzi P; Angelucci L
J Neurosci Res; 2001 Oct; 66(2):262-5. PubMed ID: 11592122
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional surface mapping of hippocampal atrophy progression from MCI to AD and over normal aging as assessed using voxel-based morphometry.
Chételat G; Fouquet M; Kalpouzos G; Denghien I; De la Sayette V; Viader F; Mézenge F; Landeau B; Baron JC; Eustache F; Desgranges B
Neuropsychologia; 2008; 46(6):1721-31. PubMed ID: 18289618
[TBL] [Abstract][Full Text] [Related]
12. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
[TBL] [Abstract][Full Text] [Related]
13. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal atrophy correlates with the severity of cognitive decline.
Yavuz BB; Ariogul S; Cankurtaran M; Oguz KK; Halil M; Dagli N; Cankurtaran ES
Int Psychogeriatr; 2007 Aug; 19(4):767-77. PubMed ID: 17005070
[TBL] [Abstract][Full Text] [Related]
15. Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone.
Belanoff JK; Jurik J; Schatzberg LD; DeBattista C; Schatzberg AF
J Mol Neurosci; 2002; 19(1-2):201-6. PubMed ID: 12212781
[TBL] [Abstract][Full Text] [Related]
16. Plasma cortisol levels, brain volumes and cognition in healthy elderly men.
MacLullich AM; Deary IJ; Starr JM; Ferguson KJ; Wardlaw JM; Seckl JR
Psychoneuroendocrinology; 2005 Jun; 30(5):505-15. PubMed ID: 15721061
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease.
Teunissen CE; van der Flier WM; Scheltens P; Duits A; Wijnstok N; Nijpels G; Dekker JM; Blankenstein RM; Heijboer AC
J Alzheimers Dis; 2015; 44(3):809-13. PubMed ID: 25352450
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
[TBL] [Abstract][Full Text] [Related]
19. Patterns of neuropsychological impairment in MCI patients with small subcortical infarcts or hippocampal atrophy.
Gainotti G; Ferraccioli M; Vita MG; Marra C
J Int Neuropsychol Soc; 2008 Jul; 14(4):611-9. PubMed ID: 18577290
[TBL] [Abstract][Full Text] [Related]
20. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
